<p>Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation.</p>

Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation.

<p>Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare&nbsp;Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation.</p>

Healthcare: Are Biotech Stocks Really Overvalued?

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Healthcare: Are Biotech Stocks Really Overvalued?

Sign up to save your podcasts

Healthcare: Are Biotech Stocks Really Overvalued?

Healthcare: Are Biotech Stocks Really Overvalued?

More shows like Industry Focus

Motley Fool Hidden Gems Investing

Motley Fool Answers

Rule Breaker Investing

MarketFoolery